Biology of Blood and Marrow Transplantation
Volume 16, Issue 2 , Pages 170-178 , February 2010

T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease

  • Cristina Iclozan

      Affiliations

    • Immunology and Blood & Marrow Transplantation Programs, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
    • ,
  • Yu Yu

      Affiliations

    • Immunology and Blood & Marrow Transplantation Programs, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
    • ,
  • Chen Liu

      Affiliations

    • Department of Pathology, Immunology and Laboratory Medicine, University of Florida, College of Medicine, Gainesville, Florida
    • ,
  • Yaming Liang

      Affiliations

    • Immunology and Blood & Marrow Transplantation Programs, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
    • ,
  • Tangsheng Yi

      Affiliations

    • Graduate School of Biological Science, City of Hope National Medical Center, Duarte, California
    • ,
  • Claudio Anasetti

      Affiliations

    • Immunology and Blood & Marrow Transplantation Programs, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
    • Department of Oncologic Sciences, University of South Florida, Tampa, Florida
    • ,
  • Xue-Zhong Yu

      Affiliations

    • Immunology and Blood & Marrow Transplantation Programs, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
    • Department of Oncologic Sciences, University of South Florida, Tampa, Florida
    • Corresponding Author InformationCorrespondence and reprint requests: Xue-Zhong Yu, MD, H. Lee Moffitt Cancer Center & Research Institute, SRB-2, 12902 Magnolia Drive, Tampa, FL 33512.

Received 3 August 2009 ,Accepted 25 September 2009.

References 

  1. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature. 2001;411:385–389
  2. Blazar BR, Murphy WJ. Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos Trans R Soc Lond B Biol Sci. 2005;360:1747–1767
  3. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123–1132
  4. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133–1141
  5. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235–238
  6. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006;441:231–234
  7. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179–189
  8. Chen X, Das R, Komorowski R, et al. Blockade of interleukin-6 signaling augments regulatory T cell reconstitution and attenuates the severity of graft versus host disease. Blood. 2009;114:891–900
  9. Ivanov , McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell. 2006;126:1121–1133
  10. Yang XO, Panopoulos AD, Nurieva R, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem. 2007;282:9358–9363
  11. Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008;28:29–39
  12. Ferrara JL. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol. 1993;5:794–799
  13. Krenger W, Hill GR, Ferrara JL. Cytokine cascades in acute graft-versus-host disease. Transplantation. 1997;64:553–558
  14. Via CS, Rus V, Gately MK, Finkelman FD. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J Immunol. 1994;153:4040–4047
  15. Williamson E, Garside P, Bradley JA, Mowat AM. IL-12 is a central mediator of acute graft-versus-host disease in mice. J Immunol. 1996;157:689–699
  16. Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood. 2009;113:1365–1374
  17. Kappel LW, Goldberg GL, King CG, et al. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood. 2009;113:945–952
  18. Yi T, Zhao D, Lin CL, et al. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood. 2008;112:2101–2110
  19. Edinger M, Hoffmann P, Ermann J, et al. CD4 + CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9:1144–1150
  20. Liang Y, Liu C, Djeu JY, et al. Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects. Blood. 2008;111:954–962
  21. Negrin RS, Contag CH. In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease. Nat Rev. 2006;6:484–490
  22. Yu Y, Iclozan C, Yamazaki T, et al. Abundant c-FLIP expression determines resistance of Th17 cells to activation-induced cell death. Blood. 2009;114:1026–1028
  23. Yu XZ, Bidwell SJ, Martin PJ, Anasetti C. Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens. J Immunol. 2001;166:5835–5839
  24. Murphy WJ, Welniak LA, Taub DD, et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest. 1998;102:1742–1748
  25. Nikolic B, Lee S, Bronson RT, Grusby MJ, Sykes M. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest. 2000;105:1289–1298
  26. Yang YG, Dey BR, Sergio JJ, Pearson DA, Sykes M. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest. 1998;102:2126–2135
  27. Burman AC, Banovic T, Kuns RD, et al. IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood. 2007;110:1064–1072
  28. Mauermann N, Burian J, von Garnier C, et al. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17 + CD4 + T-cell-mediated graft-versus-host disease. Am J Respir Crit Care Med. 2008;178:379–388
  29. Nurieva R, Yang XO, Chung Y, Dong C. Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J Immunol. 2009;182:2565–2568
  30. Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008;29:44–56
  31. Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol. 2007;8:247–256
  32. Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med. 2006;203:2785–2791
  33. Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 2008;112:362–373
  34. Nakae S, Iwakura Y, Suto H, Galli SJ. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258–1268
  35. Yi T, Chen Y, Wang L, et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft versus host disease. Blood. 2009;114:3101–3112

 Financial disclosure: See Acknowledgments on page 177.

PII: S1083-8791(09)00446-7

doi: 10.1016/j.bbmt.2009.09.023

Biology of Blood and Marrow Transplantation
Volume 16, Issue 2 , Pages 170-178 , February 2010

Article Tools

* Image Usage & Resolution